title: CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc).
abstract: Cellular prion protein (PrP(c)) is a glycosylphosphatidylinositol (GPI)-anchored protein (GPI-AP) constitutively expressed by neurons but also in hematopoietic cells. In trasmissible spongiform encephalopathies, the protease-resistant form of prion (PrP (s c)) converts the host PrP(c) into the pathologic form. We have investigated PrP(c) expression in hematopoietic cells from paroxysmal nocturnal hemoglobinuria (PNH). In this disease, due to somatic mutations in PIG-A gene, biosynthesis of the (GPI)-anchor is impaired and affected cells lack membrane expression of all GPI-AP. Normal and PNH hematopoietic progenitors and paired wild-type (WT) and PIG-A mutant cell lines were used for analysis of intracellular and surface PrP(c) expression using flow cytometry and Western blot.By flow cytometry, PrP(c) was constitutively present on normal CD34(+) cells, including more immature CD38(dim) cells, as well as hematopoietic cell lines. Similar results were obtained in purified CD34(+). Phospholipase C treatment confirmed that PrP(c) was expressed on the membrane via the GPI-anchor. In PNH patients, GPI-AP-deficient CD34(+) cells lacked PrP(c) membrane expression. PIG-A-mutated cell lines (Jurkat, K562, C(EBV), A(EBV)), in contrast to their normal counterparts, did not express surface PrP(c). However, we detected intracellular PrP(c) at approximately equivalent levels in both normal and PIG-A-mutated cells using intracellular flow cytometry and Western blotting. Cells and cell lines with PNH phenotype together with their normal counterparts may be a suitable system to explore the function of membrane PrP(c) in the hematopoietic system. Conversely, PrP(c) is a good model to elucidate the fate of GPI-AP in PIG-A-deficient cells.
authors.affiliation: Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Antonio M
authors.initials: AM
authors.lastname: Risitano
authors.forename: Karel
authors.initials: K
authors.lastname: Holada
authors.forename: Guibin
authors.initials: G
authors.lastname: Chen
authors.forename: Jan
authors.initials: J
authors.lastname: Simak
authors.forename: Jaroslav G
authors.initials: JG
authors.lastname: Vostal
authors.forename: Neal S
authors.initials: NS
authors.lastname: Young
authors.forename: Jaroslaw P
authors.initials: JP
authors.lastname: Maciejewski
mesh_terms: D018952:Antigens, CD34 / Q000032:analysis; D002462:Cell Membrane / Q000737:chemistry; D002478:Cells, Cultured; D005434:Flow Cytometry; D015870:Gene Expression; D017261:Glycosylphosphatidylinositols / Q000172:deficiency; D006412:Hematopoietic Stem Cells / Q000737:chemistry*; D006457:Hemoglobinuria, Paroxysmal / Q000097:blood* / Q000145:classification / Q000235:genetics; D006801:Humans; D020014:K562 Cells; D008565:Membrane Proteins / Q000032:analysis / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D018621:PrPC Proteins / Q000032:analysis / Q000172:deficiency* / Q000502:physiology; D010738:Type C Phospholipases / Q000494:pharmacology
chemical_list: D018952:Antigens, CD34; D017261:Glycosylphosphatidylinositols; D008565:Membrane Proteins; D018621:PrPC Proteins; C080086:phosphatidylinositol glycan-class A protein; D010738:Type C Phospholipases; D043265:Phosphatidylinositol Diacylglycerol-Lyase